Volume 3, Issue 12, Pages 1-2 (December 2007)
4 of 29
PREVIEW
FULL TEXT
FULL-TEXT PDF (205 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
DOWNLOAD IMAGES
NEED REPRINTS?
BOOKMARK ARTICLE
PHILADELPHIA — A new anti-epileptic drug, known as brivaracetam, showed promising safety and efficacy in results from a phase II study with a total of about 200 patients.
PII: S1553-3212(08)70004-9
doi:10.1016/S1553-3212(08)70004-9
© 2007 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.